J&J strikes its deal with Sail as the in vivo CAR-T space becomes increasingly crowded, with several big pharma players betting on the class.
US efforts to scrutinise overseas drug manufacturing could expose Europe’s role in supplying FDA-approved innovator and biosimilar drugs.
AbbVie's Rinvoq, Pfizer and BioNTech's Comirnaty and Incyte's Opzelura have all received their own EU drug regulatory approvals this week.
Resilience and Lilly have invested $750m to boost production of Lilly’s KwikPen to boost the US supply of diabetes and obesity medicines.
Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.
Synlogic and Caldera Therapeutics have signed a definitive merger agreement aimed at combining in an all-stock transaction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results